Team Colitco

Dexus Strengthens Board With Independent Director Appointment

Nipah Virus India Cases Raise Regional Health Alert

ResMed Q2 FY26 Results Show Strong Revenue Growth and Margin Expansion

Clarity Pharmaceuticals Advances Multiple Registrational Trials, Backed by $226m Cash Reserve

PLS December 2025 Quarterly Reveals Strong Sales And Cash Growth

Surefire Rersources Delivers Exceptional Gold Result While Advancing Diversified Project Portfolio

Surefire Resources Delivers Exceptional Gold Results While Advancing Diversified Project Portfolio

Microsoft Q2 Earnings Drive Market Reactions Across Big Tech

Microsoft Cloud Revenue Exceeds $50 Billion As AI Business Powers Q2 Growth

Bragg Comments On Islam Ignite Political Storm And National Unity Debate

IGO Limited Posts Resilient December Quarter as Greenbushes margin Strengthen and CGP3 Commissioning Advances

IGO Limited Posts Resilient December Quarter as Greenbushes Margins Strengthen and CGP3 Commissioning Advances

COLITCO LLP accepts no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. COLITCO LLP or an associate may receive a commission for funds raised.

↑

Team Colitco

Recent Posts

Categories

Disclaimer

Categories

Trending Posts